Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study

Ray, Joel G.; Vermeulen, Marian J.; Schull, Michael J.; Redelmeier, Donald A.

doi:10.1016/s0140-6736(05)67726-4

Cited by 905 publications

(653 citation statements)

References 33 publications

Supporting

Mentioning

605

Contrasting

Unclassified

Order By: Relevance

“…The role of GH combined with SGA and/or preterm delivery on future CVD has been addressed in a few studies 5, 20, 24, 28. These studies support our findings, but have limitations.…”

Section: Discussionsupporting

confidence: 77%

“…A possible relationship between GH and risk of maternal CVD has been studied to a much smaller extent. While several studies have reported a significant association between GH and subsequent CVD,5, 19, 20, 23, 24, 25, 26, 27, 28, 29, 30 only 4 of these had a comparable cohort size and a similar follow‐up time compared with our study 19, 20, 23, 29. None of these studies looked at the combined effects of GH, SGA infant, preterm delivery, and parity as predictors of subsequent CVD.…”

Section: Introductionmentioning

confidence: 68%

“…A Swedish study of GH or preeclampsia combined with SGA or preterm delivery found an incidence rate ratio of 2.6 for subsequent risk of ischemic heart disease; however, most analyses combined GH and preeclampsia 20. Two studies of the combination of maternal placental syndrome with SGA/preterm delivery found an increased risk of CVD, but without specifying the types of hypertensive pregnancy disorders 24, 28. The study presented here is the first large cohort study analyzing GH as a separate disorder combined with SGA and/or preterm delivery and we observed a strong and significant increased risk of CVD in these women.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Association Between Gestational Hypertension and Risk of Cardiovascular Disease Among 617 589 Norwegian Women

Riise

Sulo

Tell

et al. 2018

JAHA

View full text Add to dashboard Cite

BackgroundPreeclampsia and gestational hypertension (GH) are the most common hypertensive pregnancy disorders. Preeclampsia has been linked to increased risk of cardiovascular disease (CVD), but a similar association for GH has not been established. We aimed to determine the association between GH and subsequent CVD, and explore the additional role of small‐for‐gestational‐age infants, preterm delivery, and parity.Methods and ResultsData from the Medical Birth Registry of Norway were linked to the Cardiovascular Disease in Norway project and the Norwegian Cause of Death Registry. Hazard ratios and 95% confidence intervals were computed using Cox proportional hazard regression, comparing women with and without GH during their first and/or second pregnancy. We included all women with a first delivery from 1980 through 2009 (n=617 589) and followed them for a median of 14.3 (quartile 1–quartile 3: 6.9–21.5) years. Women with GH in the first pregnancy had 1.8‐fold (95% confidence interval, 1.7–2.0) higher risk of subsequent CVD compared with women without any hypertensive pregnancy disorder. When GH occurred in combination with small‐for‐gestational‐age infants and/or preterm delivery, the hazard ratio was 2.6 (95% confidence interval, 2.3–3.0). When women with GH were compared with women with preeclampsia, the risk of CVD was comparable when the pregnancy complications occurred in either the first or second pregnancy but was significantly higher for preeclampsia without complications when the disorder occurred in both pregnancies.Conclusions GH was associated with increased risk of subsequent CVD, and the highest risk was observed when GH was combined with small‐for‐gestational‐age infants and/or preterm delivery.

show abstract

“…The role of GH combined with SGA and/or preterm delivery on future CVD has been addressed in a few studies 5, 20, 24, 28. These studies support our findings, but have limitations.…”

Section: Discussionsupporting

confidence: 77%

Section: Introductionmentioning

confidence: 68%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Association Between Gestational Hypertension and Risk of Cardiovascular Disease Among 617 589 Norwegian Women

Riise

Sulo

Tell

et al. 2018

JAHA

View full text Add to dashboard Cite

show abstract

“…62, 63, 64, 65 In a recent JAHA article by Riise et al, the HR for risk of CVD associated with GH plus small‐for‐gestational‐age and/or preterm delivery was 2.6, compared with 1.8 for GH alone, 1.1 for small for gestational age alone, and 1.3 for preterm delivery alone 52. In terms of midterm risk, the study by Egeland et al in a recent issue of JAHA demonstrated that over median follow‐up of 7.1 years, the combination of preeclampsia and GH with a very preterm delivery (<32 weeks gestation) was associated with a markedly elevated risk of CVD that is 12.7‐fold higher than normotensive term pregnancies 58.…”

Section: Additional Impact Of Other Pregnancy‐related Complications Omentioning

confidence: 99%

Hypertensive Disorders of Pregnancy and Future Maternal Cardiovascular Risk

Ying

Catov

Ouyang

2018

JAHA

178

119

View full text Add to dashboard Cite

“…Furthermore, it has been clearly shown that preeclampsia places women at long-term risk for CV diseases and that careful follow-up and aggressive preventive strategies are recommended. [32][33][34] For example, a meta-analysis which includes 43 million women and almost 200 00 women with preeclampsia showed that women who had preeclampsia are 2.7 times more likely to develop hypertension, and almost twice more likely to have ischemic heart disease, stroke or venous thromboembolism. 34 …”

Section: Hormone Replacement Therapy and Bpmentioning

confidence: 99%

Hypertension in women

Pimenta

2011

Hypertens Res

View full text Add to dashboard Cite

Hypertension is an important modifiable risk factor for cardiovascular (CV) morbidity and mortality, and a highly prevalent condition in both men and women. However, the prevalence of hypertension is predicted to increase more among women than men. Combined oral contraceptives (COCs) can induce hypertension in a small group of women and, increase CV risk especially among those with hypertension. Both COC-related increased CV risk and blood pressure (BP) returns to pretreatment levels by 3 months of its discontinuation. The effects of menopause and hormone replacement therapy (HRT) on BP are controversial, and COCs and HRT containing the new generation progestin drospirenone are preferred in women with established hypertension. Despite the high incidence of cancer in women, CV disease remains the major cause of death in women and comparable benefit of antihypertensive treatment have been demonstrated in both women and men. Hypertension Research (2012) 35, 148-152; doi:10.1038/hr.2011; published online 1 December 2011Keywords: blood pressure; treatment; women INTRODUCTIONHypertension is an important modifiable risk factor for cardiovascular (CV) morbidity and mortality, and a highly prevalent condition in both men and women. Blood pressure (BP) is generally higher in men than in women regardless of age. Mean systolic BP in the overall population increases progressively throughout adult life in both men and women. During early adulthood mean systolic BP is higher in men than women, but the subsequent rate of rise in BP is steeper for women than men. Prevalence and severity of hypertension increase markedly with advancing age in women, such that a higher percentage of women than men have high BP after 65 years. 1-5 Furthermore, BP control is more difficult to achieve in older women. Data from the Framingham Heart Study showed gender differences in BP control rates and in the pattern of antihypertensive medications prescribed. 3 An age-related decrease in BP control rates were more pronounced in women than in men. Among the oldest participants with hypertension, only 23% of women (vs. 38% of men) were controlled to BP o140/90 mm Hg. Treatment with thiazide diuretics was also more frequent among women than men (38 vs. 23%). It is unknown whether the age-related decline in BP control among women is related to true treatment resistance because of biological factors or to inappropriate drug choices in the clinical setting.This article discusses practical aspects related to hypertension in women and some topics are discussed in detail in separate articles in this special review edition.

show abstract

Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study

Cited by 905 publications

References 33 publications

Association Between Gestational Hypertension and Risk of Cardiovascular Disease Among 617 589 Norwegian Women

Association Between Gestational Hypertension and Risk of Cardiovascular Disease Among 617 589 Norwegian Women

Hypertensive Disorders of Pregnancy and Future Maternal Cardiovascular Risk

Hypertension in women

Contact Info

Product

Resources

About